Experiencing stigmatization during the COVID-19 pandemic: a qualitative study among healthcare workers.

Experiencing stigmatization during the COVID-19 pandemic: a qualitative study among healthcare workers.

Publication date: Sep 09, 2025

Healthcare workers (HCWs) played a crucial role in dealing with the COVID-19 pandemic. In addition to increased workloads, they were confronted with stigmatization due to their work in the health sector. Guided by the Health Stigma and Discrimination Framework (HSDF), this study aimed to explore the experiences of stigmatization of HCWs in Germany using semi-structured interviews (N = 34) and investigate effective coping strategies and existing needs in this context. An intersectional perspective was adopted to examine the relevance of multiple stigmatization. The data was analyzed using qualitative content analysis. The results indicated that HCWs were affected by multiple forms of stigmata (public, anticipated, and self-stigma) from different sources (e. g., in private, public, and work contexts). Different drivers for stigmatization were mentioned, but the fear of infection and its consequences were central. The consequences of the stigmatization experience had a primarily restrictive effect on quality of life and social participation on a psychological, social, and professional level. To cope with the stigmatization, those affected reported behavioral and cognitive coping strategies. In addition to the stigmatization in the context of the COVID-19 pandemic, it became apparent that HCWs experienced additional stigmatization primarily due to their (female) gender, but also due to their profession (i. e., nursing) and (young) age. Implications for research, policy, and practice were derived from the results. Future research on the topic should also adopt an intersectional perspective in order to be able to depict the complexity of stigmatization processes adequately.

Open Access PDF

Concepts Keywords
Covid Adaptation, Psychological
Germany Adult
Healthcare Coping strategies
Increased COVID-19
Stigmatization Female
Germany
Health Personnel
Health personnel
Humans
Intersectionality
Male
Middle Aged
Nurses
Pandemics
Physicians
Qualitative research
Qualitative Research
Quality of Life
SARS-CoV-2
Social Stigma
Stigma

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease IDO role
disease MESH infection
disease IDO quality
pathway REACTOME Reproduction
disease MESH Infectious Diseases
disease MESH uncertainty
disease IDO pathogen
disease MESH depression
disease MESH anxiety disorders
disease IDO process
disease MESH delayed treatment
disease MESH death
disease MESH anxiety
disease MESH psychological distress
disease MESH mental illnesses
pathway REACTOME Translation
drug DRUGBANK Isoxaflutole
disease MESH tics
drug DRUGBANK Coenzyme M
disease MESH educational level
drug DRUGBANK Etoperidone
drug DRUGBANK Esomeprazole
pathway REACTOME Immune System
disease MESH loneliness
disease IDO entity
drug DRUGBANK Clotiazepam
disease MESH compassion fatigue
disease MESH burnout
drug DRUGBANK Trestolone
disease MESH emergencies
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Deoxy-2-Fluoro-B-D-Cellotrioside
disease MESH insomnia
disease MESH bullying
disease MESH AIDS
disease MESH STDs
disease IDO intervention
disease MESH social stigma
drug DRUGBANK Diethylstilbestrol
disease MESH suicidal ideation
disease MESH Coronavirus Infections
drug DRUGBANK Guanosine

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *